PERTH, Australia--(BUSINESS WIRE)--AION Diagnostics Inc, a molecular imaging company developing medical imaging agents, today announced the expansion into new applications based on the modified porous silicon (mpSi) platform. The new products target the pre-clinical small animal imaging sector and have been developed as a result of advancements in the Company's core human healthcare division.
